Encompass Health Co. (NYSE:EHC) Shares Sold by BCR Wealth Strategies LLC

BCR Wealth Strategies LLC decreased its holdings in Encompass Health Co. (NYSE:EHC) by 30.0% in the fourth quarter, HoldingsChannel.com reports. The firm owned 4,671 shares of the company’s stock after selling 2,000 shares during the quarter. Encompass Health makes up 0.2% of BCR Wealth Strategies LLC’s holdings, making the stock its 17th biggest holding. BCR Wealth Strategies LLC’s holdings in Encompass Health were worth $431,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the business. MassMutual Private Wealth & Trust FSB raised its holdings in shares of Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after acquiring an additional 137 shares during the last quarter. UMB Bank n.a. raised its holdings in shares of Encompass Health by 387.7% during the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after acquiring an additional 252 shares during the last quarter. V Square Quantitative Management LLC raised its holdings in shares of Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after acquiring an additional 140 shares during the last quarter. Avior Wealth Management LLC acquired a new position in shares of Encompass Health during the third quarter valued at approximately $40,000. Finally, Tompkins Financial Corp acquired a new position in shares of Encompass Health during the fourth quarter valued at approximately $46,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on EHC shares. William Blair reissued an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. StockNews.com lowered Encompass Health from a “buy” rating to a “hold” rating in a research report on Friday, February 7th. Barclays upped their price target on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, February 7th. Truist Financial restated a “buy” rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $110.00 price objective on shares of Encompass Health in a research report on Tuesday. One analyst has rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $107.67.

Encompass Health Stock Up 0.7 %

NYSE:EHC opened at $99.37 on Wednesday. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock’s fifty day moving average is $96.14 and its two-hundred day moving average is $95.41. Encompass Health Co. has a 52 week low of $72.38 and a 52 week high of $104.55. The stock has a market capitalization of $10.01 billion, a price-to-earnings ratio of 22.28, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 18.06% and a net margin of 8.48%. Research analysts anticipate that Encompass Health Co. will post 4.76 EPS for the current year.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.